Inactive Instrument
LYSOGENE Share Price
Stocks
LYS
FR0013233475
Biotechnology & Medical Research
OTC Markets Traded
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 09/05/2014 | |
| Director of Finance/CFO | - | 01/11/2022 | |
Marie Trad
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 54 | 22/05/2019 | |
Peter Lichtlen
BRD | Director/Board Member | 58 | 01/04/2018 |
Carole Deffez
BRD | Director/Board Member | - | 26/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 55.26L | |
| -4.10% | -8.35% | +38.48% | +66.99% | 6.62TCr | |
| -0.41% | +3.27% | +10.46% | +73.74% | 5.52TCr | |
| +0.74% | +4.04% | +12.18% | +91.76% | 5.28TCr | |
| -0.44% | +1.49% | +26.27% | +49.74% | 4.55TCr | |
| -1.14% | +2.11% | +21.83% | +126.39% | 4.39TCr | |
| -3.94% | -0.80% | +254.38% | +922.88% | 4.16TCr | |
| -1.67% | +8.06% | +14.17% | +56.67% | 3.4TCr | |
| -8.38% | -9.01% | +25.65% | -1.82% | 2.58TCr | |
| +1.30% | +4.94% | +38.23% | +28.03% | 2.35TCr | |
| Average | -1.76% | +3.43% | +49.07% | +157.15% | 4.32TCr | |
| Weighted average by Cap. | -1.82% | +3.43% | +47.75% | +159.87% |
Employees
22
